These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 30324244)
1. Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1. Oyama R; Kito F; Qiao Z; Sakumoto M; Noguchi R; Takahashi M; Toki S; Tanzawa Y; Yoshida A; Kawai A; Kondo T In Vitro Cell Dev Biol Anim; 2018 Dec; 54(10):770-778. PubMed ID: 30324244 [TBL] [Abstract][Full Text] [Related]
2. Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma. Boro A; Prêtre K; Rechfeld F; Thalhammer V; Oesch S; Wachtel M; Schäfer BW; Niggli FK Int J Cancer; 2012 Nov; 131(9):2153-64. PubMed ID: 22323082 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway. Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300 [TBL] [Abstract][Full Text] [Related]
4. High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition. Awad O; Yustein JT; Shah P; Gul N; Katuri V; O'Neill A; Kong Y; Brown ML; Toretsky JA; Loeb DM PLoS One; 2010 Nov; 5(11):e13943. PubMed ID: 21085683 [TBL] [Abstract][Full Text] [Related]
5. Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma. Rao DD; Jay C; Wang Z; Luo X; Kumar P; Eysenbach H; Ghisoli M; Senzer N; Nemunaitis J Mol Ther; 2016 Aug; 24(8):1412-22. PubMed ID: 27166877 [TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of a novel patient-derived Ewing sarcoma cell line, NCC-ES2-C1. Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Akiyama T; Nakagawa R; Kamio S; Hirabayashi K; Ozawa I; Kikuta K; Kondo T Hum Cell; 2022 Jul; 35(4):1262-1269. PubMed ID: 35441357 [TBL] [Abstract][Full Text] [Related]
8. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. Oyama R; Kito F; Sakumoto M; Shiozawa K; Toki S; Endo M; Yoshida A; Kawai A; Kondo T In Vitro Cell Dev Biol Anim; 2018 May; 54(5):392-399. PubMed ID: 29626278 [TBL] [Abstract][Full Text] [Related]
9. A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing's sarcoma cells, interacts with the EWS-FLI1 and partner proteins. Thangaretnam KP; Gopisetty G; Ramanathan P; Rajkumar T Sci Rep; 2017 Aug; 7(1):7172. PubMed ID: 28775288 [TBL] [Abstract][Full Text] [Related]
11. Ewing's sarcoma: general insights from a rare model. Davis S; Meltzer PS Cancer Cell; 2006 May; 9(5):331-2. PubMed ID: 16697953 [TBL] [Abstract][Full Text] [Related]
12. Specific and sensitive detection of the EWS/FLI1 fusion protein in Ewing's sarcoma by Western blotting. Wang M; Nilsson G; Carlberg M; Dricu A; Wejde J; Kreicbergs A; Larsson O Virchows Arch; 1998 Feb; 432(2):131-4. PubMed ID: 9504857 [TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of a clonal human extraskeletal Ewing's sarcoma cell line, EES1. Hatori M; Doi H; Watanabe M; Sasano H; Hosaka M; Kotajima S; Urano F; Hata J; Kokubun S Tohoku J Exp Med; 2006 Nov; 210(3):221-30. PubMed ID: 17077599 [TBL] [Abstract][Full Text] [Related]
15. Establishment of novel patient-derived models of dermatofibrosarcoma protuberans: two cell lines, NCC-DFSP1-C1 and NCC-DFSP2-C1. Oyama R; Kito F; Qiao Z; Sakumoto M; Shiozawa K; Toki S; Yoshida A; Kawai A; Kondo T In Vitro Cell Dev Biol Anim; 2019 Jan; 55(1):62-73. PubMed ID: 30411273 [TBL] [Abstract][Full Text] [Related]
16. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group. Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546 [TBL] [Abstract][Full Text] [Related]
17. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma. Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072 [TBL] [Abstract][Full Text] [Related]
18. Herceptin down-regulates HER-2/neu and vascular endothelial growth factor expression and enhances taxol-induced cytotoxicity of human Ewing's sarcoma cells in vitro and in vivo. Guan H; Jia SF; Zhou Z; Stewart J; Kleinerman ES Clin Cancer Res; 2005 Mar; 11(5):2008-17. PubMed ID: 15756027 [TBL] [Abstract][Full Text] [Related]
19. Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift. Bridge JA; Fidler ME; Neff JR; Degenhardt J; Wang M; Walker C; Dorfman HD; Baker KS; Seemayer TA Am J Surg Pathol; 1999 Feb; 23(2):159-65. PubMed ID: 9989842 [TBL] [Abstract][Full Text] [Related]
20. Adamantinoma-like Ewing's sarcoma with EWS-FLI1 fusion gene: a case report. Fujii H; Honoki K; Enomoto Y; Kasai T; Kido A; Amano I; Kumamoto M; Morishita T; Mii Y; Nonomura A; Takakura Y Virchows Arch; 2006 Nov; 449(5):579-84. PubMed ID: 17016721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]